Belite Bio Inc ADR (BLTE) had the highest return between April 1, 2022 and September 30, 2022 by a mid-cap US stock, returning 168.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Belite Bio Inc ADR (BLTE) | 4/1/2022 - 9/30/2022 | 168.4% |
Akero Therapeutics (AKRO) | 4/1/2022 - 9/30/2022 | 137.45% |
Torm PLC Class A (TRMD) | 4/1/2022 - 9/30/2022 | 137.12% |
Rhythm Pharmaceuticals (RYTM) | 4/1/2022 - 9/30/2022 | 113.23% |
Cogent Biosciences (COGT) | 4/1/2022 - 9/30/2022 | 99.47% |
Scorpio Tankers (STNG) | 4/1/2022 - 9/30/2022 | 96.67% |
Terns Pharmaceuticals (TERN) | 4/1/2022 - 9/30/2022 | 96.33% |
International Seaways (INSW) | 4/1/2022 - 9/30/2022 | 95.52% |
New Oriental Education & Technology (EDU) | 4/1/2022 - 9/30/2022 | 94.88% |
Wave Life Sciences (WVE) | 4/1/2022 - 9/30/2022 | 75.24% |
H&R Block (HRB) | 4/1/2022 - 9/30/2022 | 64.99% |
CECO Environmental (CECO) | 4/1/2022 - 9/30/2022 | 61.2% |
Griffon (GFF) | 4/1/2022 - 9/30/2022 | 57.99% |
TAL Education (TAL) | 4/1/2022 - 9/30/2022 | 54.86% |
TransMedics (TMDX) | 4/1/2022 - 9/30/2022 | 54.02% |
Catalyst Pharmaceuticals (CPRX) | 4/1/2022 - 9/30/2022 | 53.84% |
Alliance Resource Partners (ARLP) | 4/1/2022 - 9/30/2022 | 52.67% |
Xometry (XMTR) | 4/1/2022 - 9/30/2022 | 52.54% |
Recursion Pharmaceuticals (RXRX) | 4/1/2022 - 9/30/2022 | 48.4% |
PBF Energy (PBF) | 4/1/2022 - 9/30/2022 | 44.99% |
Huron Consulting (HURN) | 4/1/2022 - 9/30/2022 | 44.94% |
ELF Beauty (ELF) | 4/1/2022 - 9/30/2022 | 43.97% |
Bel Fuse B (BELFB) | 4/1/2022 - 9/30/2022 | 42.89% |
Calix (CALX) | 4/1/2022 - 9/30/2022 | 42.65% |
Modine Manufacturing (MOD) | 4/1/2022 - 9/30/2022 | 41.58% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
